Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
MD.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MD.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MD.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LP.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LP.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LP.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LP.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.99ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.99ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.99ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.99NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBF.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBF.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.343ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.343ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.343ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.343NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.4.17 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.4.17 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.17 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.17 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.25.1.2 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.25.1.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.25.1.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.25.1.2 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.409ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.409ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.409ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.409NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.83ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.83ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.83ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.83NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.310ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.310ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.310ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.310NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.362.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.362.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.362.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.362.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.162ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.162ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.162ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used